- Home
- ALCE vs EDSA Comparison
ALCE vs EDSA Comparison
Compare ALCE & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALCE
- EDSA
- Stock Information
- Founded
- ALCE 2019
- EDSA 2015
- Country
- ALCE United States
- EDSA Canada
- Employees
- ALCE N/A
- EDSA N/A
- Industry
- ALCE Power Generation
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- ALCE Utilities
- EDSA Health Care
- Exchange
- ALCE Nasdaq
- EDSA Nasdaq
- Market Cap
- ALCE 3.7M
- EDSA 6.1M
- IPO Year
- ALCE N/A
- EDSA N/A
- Fundamental
- Price
- ALCE $0.84
- EDSA $1.73
- Analyst Decision
- ALCE
- EDSA Strong Buy
- Analyst Count
- ALCE 0
- EDSA 1
- Target Price
- ALCE N/A
- EDSA $21.00
- AVG Volume (30 Days)
- ALCE 98.9K
- EDSA 30.6K
- Earning Date
- ALCE 11-19-2024
- EDSA 02-07-2025
- Dividend Yield
- ALCE N/A
- EDSA N/A
- EPS Growth
- ALCE N/A
- EDSA N/A
- EPS
- ALCE N/A
- EDSA N/A
- Revenue
- ALCE N/A
- EDSA N/A
- Revenue This Year
- ALCE N/A
- EDSA N/A
- Revenue Next Year
- ALCE N/A
- EDSA N/A
- P/E Ratio
- ALCE N/A
- EDSA N/A
- Revenue Growth
- ALCE N/A
- EDSA N/A
- 52 Week Low
- ALCE $0.74
- EDSA $1.55
- 52 Week High
- ALCE $140.75
- EDSA $5.99
- Technical
- Relative Strength Index (RSI)
- ALCE 28.33
- EDSA 31.51
- Support Level
- ALCE $0.75
- EDSA $1.73
- Resistance Level
- ALCE $0.84
- EDSA $1.99
- Average True Range (ATR)
- ALCE 0.11
- EDSA 0.19
- MACD
- ALCE 0.03
- EDSA 0.02
- Stochastic Oscillator
- ALCE 19.04
- EDSA 18.00
About ALCE Alternus Clean Energy Inc.
Alternus Clean Energy Inc is an international independent clean energy producer. It develops, installs, owns and operates a diverse portfolio of utility-scale solar photovoltaic power stations (PV parks) in Europe and the USA as a long-term owner. The solar parks benefit from long-term government offtake contracts and/or Power Purchase Agreements (PPAs) with investment grade off-takers, plus energy sales to local power grids. It has approximately 8 operating parks, a total of 44 MWp in operation.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.